Provenance

Created by SPS and the Faculty of Sexual and Reproductive Health (FSRH), with the support of specialist stakeholders working within clinical practice, for contraception commonly supplied or administered within reproductive services.

PGD template attachment

The template PGD is attached below to download and use in conjunction with our implementation advice.

• LNG IUD National PGD template V2.2 FINAL April 2024 · Word · 75 KB

Updated FSRH Guidance 9th May 2024

On the 9th May 2024 the FSRH CEU issued a statement on the extended use of all 52mg LNG-IUDs for up to eight years for contraception.  The recommendation is as follows:

The FSRH IUC GDG support extended use of any 52mg LNG-IUD for up to eight years for contraception if the user is under 45 years old at the time of insertion. There is insufficient evidence to support use of any 52mg LNG-IUD beyond eight years for contraception. If an individual presents for replacement of the device after eight years, criteria for reasonably excluding pregnancy must be met, as per FSRH guidance

The SPS PGD template will be updated to reflect this updated guidance – anticipated publication is late July 2024.

More reproductive health PGD templates

• Copper Intrauterine Device (Cu-IUD)
• Lidocaine 10mg/ml spray for IUC insertion or removal
• Lidocaine plus prilocaine cream for IUC insertion or removal
• Medroxyprogesterone acetate (SC-DMPA) injection for contraception
• Medroxyprogesterone acetate (DMPA) IM injection for contraception
• Progestogen only pill (POP) for contraception
• Combined hormonal contraceptive transdermal patch
• Combined oral hormonal contraceptive (COC) in reproductive health
• Combined hormonal contraceptive vaginal ring
• Ulipristal acetate 30mg tablets for emergency contraception
• Levonorgestrel 1500 microgram tablets for emergency contraception
• Etonogestrel (e.g. Nexplanon®) implant for contraception
• Lidocaine injection for subdermal etonogestrel in contraception

All PGD templates

Update history